| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 32.00▲ | 31.78▲ | 31.92▲ | 33.06▼ | 31.55▲ |
| MA10 | 31.87▲ | 31.93▲ | 32.29▼ | 32.96▼ | 31.55▲ |
| MA20 | 31.74▲ | 32.31▼ | 32.76▼ | 31.52▲ | 33.02▼ |
| MA50 | 31.89▲ | 33.08▼ | 33.61▼ | 30.84▲ | 28.06▲ |
| MA100 | 32.25▼ | 33.54▼ | 31.90▲ | 33.83▼ | 20.03▲ |
| MA200 | 32.77▼ | 31.78▲ | 31.28▲ | 31.13▲ | 16.72▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.064▲ | 0.001▲ | -0.106▼ | 0.148▲ | -0.488▼ |
| RSI | 62.745▲ | 41.222▼ | 37.096▼ | 50.964▲ | 50.317▲ |
| STOCH | 94.799▲ | 23.879 | 18.485▼ | 62.415 | 61.976 |
| WILL %R | -8.696▲ | -54.015 | -70.283 | -49.262 | -28.166 |
| CCI | 138.720▲ | -19.358 | -86.727 | 7.458 | 38.019 |
| MA | $SRRK Price Crossed Below MA(13) | Set Alert |
|
Friday, June 13, 2025 01:15 PM
Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy (SMA) and other ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 32.74 | 32.81 | 31.44 | 32.07 | 473,017 |
| 13/06/25 | 32.48 | 33.47 | 32.03 | 32.45 | 646,476 |
| 12/06/25 | 32.82 | 34.20 | 32.66 | 33.32 | 586,448 |
| 11/06/25 | 34.44 | 34.74 | 32.97 | 33.01 | 1,157,160 |
| 10/06/25 | 34.09 | 34.725 | 33.65 | 34.44 | 570,836 |
| 09/06/25 | 34.42 | 34.91 | 33.4664 | 34.07 | 692,669 |
| 06/06/25 | 34.70 | 35.74 | 33.78 | 34.23 | 1,827,681 |
| 05/06/25 | 30.63 | 34.70 | 30.36 | 34.25 | 2,542,052 |
| 04/06/25 | 30.93 | 31.865 | 30.80 | 30.82 | 1,153,345 |
| 03/06/25 | 29.87 | 31.115 | 28.83 | 30.94 | 802,664 |
|
|
||||
|
|
||||
|
|